Showing 1,021 - 1,040 results of 1,139 for search '"Neuro-oncology"', query time: 0.11s Refine Results
  1. 1021
  2. 1022

    Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue by Sander Bekeschus, Mikael Ispirjan, Eric Freund, Frederik Kinnen, Juliane Moritz, Fariba Saadati, Jacqueline Eckroth, Debora Singer, Matthias B. Stope, Kristian Wende, Christoph A. Ritter, Henry W. S. Schroeder, Sascha Marx

    Published 2022-02-01
    “…In summary, the immuno-modulatory and proapoptotic action shown in this study might be an important step forward to first clinical observational studies on the future discovery of gas plasma technology’s potential in neurosurgery and neuro-oncology especially in putative adjuvant or combinatory GBM treatment settings.…”
    Get full text
    Article
  3. 1023
  4. 1024
  5. 1025

    Bevacizumab in recurrent WHO grades II–III glioma by Soufyan Annakib, Soufyan Annakib, Valérie Rigau, Valérie Rigau, Amélie Darlix, Amélie Darlix, Catherine Gozé, Catherine Gozé, Catherine Gozé, Hugues Duffau, Hugues Duffau, Luc Bauchet, Luc Bauchet, Marta Jarlier, Michel Fabbro

    Published 2023-07-01
    “…Efficacy was assessed using the high-grade glioma 2017 Response Assessment in Neuro-Oncology criteria. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan–Meier method.ResultsEighty-one patients were included (M/F ratio: 1.7, median age at diagnosis: 38 years) among whom 46 (56.8%) had an initial diagnosis of grade II glioma. …”
    Get full text
    Article
  6. 1026
  7. 1027
  8. 1028
  9. 1029
  10. 1030

    A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value by Natacha Entz-Werlé, Laetitia Poidevin, Petr V. Nazarov, Olivier Poch, Benoit Lhermitte, Marie Pierre Chenard, Hélène Burckel, Eric Guérin, Quentin Fuchs, David Castel, Georges Noel, Laurence Choulier, Monique Dontenwill, Eric Van Dyck

    Published 2021-05-01
    “…Background: Pediatric high-grade gliomas (pHGGs) are the leading cause of mortality in pediatric neuro-oncology, displaying frequent resistance to standard therapies. …”
    Get full text
    Article
  11. 1031
  12. 1032
  13. 1033

    Systemic and local immunosuppression in glioblastoma and its prognostic significance by Aleksei A. Stepanenko, Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, Anastasiia O. Sosnovtseva, Marat P. Valikhov, Marat P. Valikhov, Anastasia A. Chernysheva, Olga V. Abramova, Konstantin A. Pavlov, Vladimir P. Chekhonin, Vladimir P. Chekhonin

    Published 2024-02-01
    “…We call for the inclusion of dynamic assessment of NLR and other blood inflammatory markers (e.g., absolute/total lymphocyte count, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, systemic immune-inflammation index, and systemic immune response index) in all neuro-oncology studies for rigorous evaluation and comparison of their individual and combinatorial prognostic/predictive significance and relative superiority.…”
    Get full text
    Article
  14. 1034
  15. 1035
  16. 1036
  17. 1037

    Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study by Ondrej Kalita, Tomas Kazda, Stefan Reguli, Radim Jancalek, Pavel Fadrus, Marek Slachta, Petr Pospisil, Lukas Krska, Jana Vrbkova, Lumir Hrabalek, Martin Smrcka, Radim Lipina

    Published 2023-04-01
    “…A consecutive cohort of unselected patients (real-world data) from three neuro-oncology cancer centers was analyzed (a total of 109 patients). …”
    Get full text
    Article
  18. 1038
  19. 1039

    Incidence of malignant brain and other central nervous system tumors (С70–C72) in Siberia and the Russian Far East by L. D. Zhuikova, E. L. Choynzonov, O. A. Ananina, L. V. Pikalova, I. N. Odintsova, G. A. Kononova

    Published 2022-02-01
    “…The development and implementation of a Neuro-Oncology Registry in accordance with the international standards will allow full analysis of the epidemiological situation of malignant brain and other central nervous system tumors.…”
    Get full text
    Article
  20. 1040